Predica Diagnostics

Predica Diagnostics is a developer of a healthcare platform designed for the field of oncology diagnostics, prognostics, and prediction of treatment response. The company's platform specializes in targeted RNA sequencing, utilizing proprietary probes and unique algorithms to enable non-invasive cervical abnormality detection in women at risk of cervical cancer. These tests generate histology-independent molecular diagnostics, predict prognosis, and produce a list of potentially successful precision medicines, empowering healthcare professionals to create personalized treatment plans for cancer patients.